Evolus · 4 hours ago
Sr. Counsel – Commercial & Compliance
Evolus, Inc. is a performance beauty company focused on delivering breakthrough products. They are seeking an experienced Senior Counsel – Commercial & Compliance to manage healthcare compliance, FDA regulatory support, and commercial contracting while collaborating with cross-functional teams to align legal advice with business strategy.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Act as subject area expert and manage Evolus’ U.S. Healthcare Compliance Program and oversee data privacy operations to ensure adherence to applicable laws, regulations, and internal policies
Provide legal and regulatory advice supporting the commercial launch and ongoing sale of Evolus products, with particular attention to FDA, FTC, and healthcare fraud and abuse laws
Review and approve promotional, sales, and educational materials to ensure compliance with FDA, FTC, and other applicable regulations
Draft, review, and negotiate commercial agreements typical of a pharmaceutical and medical aesthetics company, including: Distribution and customer agreements, Research and development agreements, Vendor, consulting, and service agreements, Marketing and sponsorship agreements
Advise cross-functional stakeholders on risk management, data privacy, intellectual property ownership, and business initiatives in compliance with company standards
Develop and deliver training programs on compliance and promotional practices for Evolus employees and field sales teams
Monitor regulatory and legislative developments to ensure Evolus’ policies and practices remain current and compliant
Collaborate cross-functionally with marketing, commercial operations, regulatory affairs, and medical affairs to align legal advice with business strategy
Assist the General Counsel on special projects and broader corporate or transactional matters as assigned
Qualification
Required
Juris Doctor (JD) from an accredited law school
Admission to a U.S. state bar (California preferred) or eligibility for Registered In-House Counsel status in California
4+ years of legal experience in a law firm and/or in-house legal department within the life sciences, pharmaceutical, or medical device industries
Demonstrated knowledge of healthcare compliance program requirements
Demonstrated knowledge of FDA and FTC regulations governing advertising and promotion
Demonstrated knowledge of anti-kickback and healthcare fraud and abuse laws
Demonstrated knowledge of data privacy laws and frameworks (e.g., GDPR, CCPA)
Strong experience reviewing and approving promotional materials for pharmaceuticals and medical devices
Excellent business judgment with an ability to balance legal risk and business objectives
Highly collaborative with strong interpersonal, communication, and organizational skills
Curiosity and enthusiasm for learning about pharmaceuticals, medical devices, and medical aesthetics
Preferred
Experience with aesthetic or cash-pay healthcare companies
Prior experience advising sales and marketing teams in a regulated environment
Experience managing compliance investigations or audits
Familiarity with privacy and data protection frameworks, including vendor due diligence and data processing agreements
Benefits
Competitive suite of medical, dental and vision benefits
Employer covered life insurance
Short-term disability
401k match
New hire equity
Long-term incentives in the form of RSUs, stock options, and/or discretionary bonuses
Mental health and wellbeing resources
Flexible paid time off program for exempt employees
Paid time off accrual plan for non-exempt employees
Holiday soft closure between the Christmas and New Years holidays
Regularly catered team meals at our Evolus Headquarters
Fully stocked kitchen (Kombucha & Coffee included)
Company
Evolus
Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.
Funding
Current Stage
Public CompanyTotal Funding
$574MKey Investors
Pharmakon AdvisorsOxford Finance LLC
2025-05-05Post Ipo Debt· $150M
2024-03-11Post Ipo Equity· $50M
2021-12-14Post Ipo Debt· $125M
Leadership Team
Recent News
2025-11-25
2025-11-24
Company data provided by crunchbase